• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活动性多发性硬化症中枢神经系统中过氧亚硝酸盐的形成。

Peroxynitrite formation within the central nervous system in active multiple sclerosis.

作者信息

Cross A H, Manning P T, Keeling R M, Schmidt R E, Misko T P

机构信息

Department of Neurology and Neurosurgery, Washington University School of Medicine, St. Louis, MO 63110, USA.

出版信息

J Neuroimmunol. 1998 Aug 1;88(1-2):45-56. doi: 10.1016/s0165-5728(98)00078-2.

DOI:10.1016/s0165-5728(98)00078-2
PMID:9688323
Abstract

Peroxynitrite, generated by the reaction of nitric oxide (NO) with superoxide at sites of inflammation, is a strong oxidant capable of damaging tissues and cells. Detection of nitrotyrosine (NT) at inflammatory sites serves as a biochemical marker for peroxynitrite-mediated damage. In this study, NT was detected immunohistochemically within autopsied CNS tissues from six of nine multiple sclerosis (MS) patients, and in most of the MS sections displaying inflammation. Nitrite and nitrate, the stable oxidation products of NO and peroxynitrite, respectively, were measured in cerebrospinal fluid samples obtained from MS patients and controls. Levels of nitrate were elevated significantly during clinical relapses of MS. These data suggest that peroxynitrite formation is a major consequence of NO produced in MS-affected CNS and implicate a role for this powerful oxidant in the pathogenesis of MS.

摘要

过氧亚硝酸盐由一氧化氮(NO)与炎症部位的超氧化物反应生成,是一种能够损伤组织和细胞的强氧化剂。在炎症部位检测硝基酪氨酸(NT)可作为过氧亚硝酸盐介导损伤的生化标志物。在本研究中,通过免疫组织化学方法在9例多发性硬化症(MS)患者中的6例尸检中枢神经系统组织中检测到了NT,并且在大多数显示炎症的MS切片中也检测到了NT。分别测量了从MS患者和对照组获得的脑脊液样本中NO和过氧亚硝酸盐的稳定氧化产物亚硝酸盐和硝酸盐。在MS临床复发期间,硝酸盐水平显著升高。这些数据表明,过氧亚硝酸盐的形成是MS影响的中枢神经系统中产生的NO的主要后果,并提示这种强氧化剂在MS发病机制中起作用。

相似文献

1
Peroxynitrite formation within the central nervous system in active multiple sclerosis.活动性多发性硬化症中枢神经系统中过氧亚硝酸盐的形成。
J Neuroimmunol. 1998 Aug 1;88(1-2):45-56. doi: 10.1016/s0165-5728(98)00078-2.
2
Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels.一氧化氮合酶存在于活动性多发性硬化症患者的脑脊液中,与脑脊液蛋白硝基酪氨酸和S-亚硝基硫醇的增加以及谷胱甘肽水平的变化有关。
J Neurosci Res. 2002 Nov 15;70(4):580-7. doi: 10.1002/jnr.10408.
3
Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis.一氧化氮代谢物测定显示多发性硬化症存在持续炎症。
J Neuroimmunol. 2003 Mar;136(1-2):112-8. doi: 10.1016/s0165-5728(02)00464-2.
4
Raised cerebrospinal fluid nitrite and nitrate levels in patients with multiple sclerosis: no correlation with disease activity.多发性硬化症患者脑脊液中亚硝酸盐和硝酸盐水平升高:与疾病活动无关。
Mult Scler. 2001 Feb;7(1):19-22. doi: 10.1177/135245850100700104.
5
Evidence for the production of peroxynitrite in inflammatory CNS demyelination.炎症性中枢神经系统脱髓鞘中过氧亚硝酸盐产生的证据。
J Neuroimmunol. 1997 Dec;80(1-2):121-30. doi: 10.1016/s0165-5728(97)00145-8.
6
Nitric oxide metabolites in CSF of patients with MS are related to clinical disease course.
Neurology. 1999 Nov 10;53(8):1880-2. doi: 10.1212/wnl.53.8.1880.
7
Nitric oxide metabolites and interleukin-6 in cerebrospinal fluid from multiple sclerosis patients.多发性硬化症患者脑脊液中的一氧化氮代谢物和白细胞介素-6
Eur J Neurol. 2002 Jul;9(4):413-8. doi: 10.1046/j.1468-1331.2002.00437.x.
8
Cyclic guanosine monophosphate (cGMP), nitrite and nitrate in the cerebrospinal fluid in meningitis, multiple sclerosis and Guillain-Barré syndrome.
Intern Med. 1995 Aug;34(8):734-7. doi: 10.2169/internalmedicine.34.734.
9
A catalyst of peroxynitrite decomposition inhibits murine experimental autoimmune encephalomyelitis.过氧亚硝酸盐分解催化剂可抑制小鼠实验性自身免疫性脑脊髓炎。
J Neuroimmunol. 2000 Jul 10;107(1):21-8. doi: 10.1016/s0165-5728(00)00242-3.
10
CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis.脑脊液一氧化氮代谢产物与多发性硬化症的活动及进展相关。
Neurology. 2004 Oct 26;63(8):1439-45. doi: 10.1212/01.wnl.0000142043.32578.5d.

引用本文的文献

1
The Use of Nitrosative Stress Molecules as Potential Diagnostic Biomarkers in Multiple Sclerosis.氮应激分子在多发性硬化症中的潜在诊断生物标志物的应用。
Int J Mol Sci. 2024 Jan 8;25(2):787. doi: 10.3390/ijms25020787.
2
Roles and regulation of microglia activity in multiple sclerosis: insights from animal models.小胶质细胞在多发性硬化症中的作用及其调控:来自动物模型的研究进展。
Nat Rev Neurosci. 2023 Jul;24(7):397-415. doi: 10.1038/s41583-023-00709-6. Epub 2023 Jun 2.
3
Investigating the Effect of Cigarette Smoking on Serum Uric Acid Levels in Multiple Sclerosis Patients: A Cross Sectional Study.
调查吸烟对多发性硬化症患者血清尿酸水平的影响:一项横断面研究。
Brain Sci. 2023 May 15;13(5):800. doi: 10.3390/brainsci13050800.
4
Analysis of shared underlying mechanism in neurodegenerative disease.神经退行性疾病共同潜在机制的分析
Front Aging Neurosci. 2022 Nov 29;14:1006089. doi: 10.3389/fnagi.2022.1006089. eCollection 2022.
5
Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model.代谢组学在局灶性多发性硬化症动物模型中比神经丝轻链更早地检测到临床无症状的神经炎症病变。
J Neuroinflammation. 2022 Oct 9;19(1):252. doi: 10.1186/s12974-022-02614-8.
6
Potential Utility of Natural Products against Oxidative Stress in Animal Models of Multiple Sclerosis.天然产物在多发性硬化症动物模型中对抗氧化应激的潜在效用
Antioxidants (Basel). 2022 Jul 29;11(8):1495. doi: 10.3390/antiox11081495.
7
Vitamin D as a Risk Factor for Multiple Sclerosis: Immunoregulatory or Neuroprotective?维生素D作为多发性硬化症的一个风险因素:免疫调节还是神经保护?
Front Neurol. 2022 May 16;13:796933. doi: 10.3389/fneur.2022.796933. eCollection 2022.
8
Role of lipoic acid in multiple sclerosis.硫辛酸在多发性硬化中的作用。
CNS Neurosci Ther. 2022 Mar;28(3):319-331. doi: 10.1111/cns.13793. Epub 2021 Dec 28.
9
Nitrosative Stress Molecules in Multiple Sclerosis: A Meta-Analysis.多发性硬化症中的亚硝化应激分子:一项荟萃分析
Biomedicines. 2021 Dec 14;9(12):1899. doi: 10.3390/biomedicines9121899.
10
Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015-2020.多发性硬化症神经保护和神经再生治疗策略的失败、中断或不确定的临床试验:2015-2020 年更新。
Drugs. 2021 Jun;81(9):1031-1063. doi: 10.1007/s40265-021-01526-w. Epub 2021 Jun 4.